Klatzmann, David
Abbas, Abul K.
Article History
First Online: 17 April 2015
Competing interests
: D.K. is an inventor of a patent application claiming low-dose IL-2 for therapy of autoimmune diseases, owned by his academic institution, and licensed to ILTOO Pharma, which he advises and in which he holds shares. A.K.A. declares no competing interests.